WHY THE HEADACHE CLINIC

We are a highly qualified, specialist medical team passionate about providing long-term, drug-free treatments for almost many subtypes of migraines.

 

The Headache Clinic is an internationally acclaimed Southern California headache and migraine treatment center. Unlike many specialists who believe headache pain originates in the brain and approach Pain with drugs, our 23 years of research and treatment have proven our view and knowledge in the hypothesis of migraine headaches initiation as it is coming closer to reality. We understand that migraine headaches have been with us ever since ancient times. Our unique treatment success rates indicate primary headache pain caused by anatomical structures of the major sensory organs outside the skull close to the brain. Therefore, migraine is not a potentially lifelong disease. However, a closer look at bioinformatics information suggested that an imbalance in the chemical concentration of the hormones, direct trauma to the brain, or high emotional impact at a given time can trigger migraine headaches.

 

At The Headache Clinic, we go after these painful structures and then nearly permanently eliminate the headache pain they cause. Each migraine headache is different, and it has a cause that specialists must figure out before starting any treatment. 

 

We use unique diagnostic methods to pinpoint the structures and processes involved in our patient’s primary migraine Pain. In addition, we use scientific physiologic knowledge to eliminate the possible causes of migraine in each patient. We do not prescribe medications for pain relief preventive or abortive measures.

 

Therefore, our patients do not experience refractory headaches and the need for emergency room or hospitalizations encounter. Even our patients, as young as ten, tolerate the procedure well.

 

We discovered & developed a drug formula of FURROW using an algorithm called SENZA-TE based on years of research, experience, and a broad neurological understanding of the 21st century. Through fortunate and challenging studies, we were able to unlock some important dynamics of the autonomous nerve system in migraine headaches. This knowledge allows our patients to not ask for alternative drugs or alternative lifestyle modifications. 

 

We are eager to introduce our research results and discovery to communities around us to improve human health and suffering. Our innovative challenges and breakthroughs in headache treatment are based on the reality of the results we achieved during years of concentrated selfless research and dedication to humanity.

 

Our treatment is not offered anywhere else in the world yet. So, for example, our migraine treatment included one session with no significant side effects or downtime. So, it makes it very comfortable for our patients to receive the treatment by traveling long distances. We reached our goal of long-term relief without the requirement of any abortive or preventive drugs. It is a beautiful mind.

migraine headache treatment
migraine headache treatment

We diagnose it before treatment.

We serve national & international patients.

Dr. OWIESY, the multispecialty-trained physician, has over 23 years of research experience in migraine, cluster, tension headaches, and other neurological conditions.

 

Headache Treatment

 

Medical research has shown that in most headache sufferers, the pain originates not from the brain but from the structures outside the skull in the properties of the sensory organs. These organs connect our brain with the earthy physical environment we are living in. Sensory organs program the brain for continuity of life. The brain, per se, seems like a computer without applications and memories.

 

Our treatment for migraine headaches and other types of headaches focuses on the structural physiology of the sensory organs. These lifeguard structures are easy to access for both diagnosis and treatment. Our focus is on primary migraine headaches; however, our diagnostic and therapeutic approach may also benefit individuals with secondary migraine headaches.

 

Our recent clinical trial on Cluster Headaches projected evidence of zygomaticotemporal Neuroma/disorganized nerve bundle as a triggering source of Episodic and Chronic Cluster Headaches (ECCH) precisely over the pinpointed temple. This clinical trial on individuals with ECCH was the subject of surgical exploration, and excision delivered long-term resolution in episodic and chronic cluster headaches over 370 days and longer. It may further light up puzzling questions and treatment options, save a life, and ease the psycho-social and financial burden on individual patients, their families, and society. This novel transitional approach is now available at our clinic for individuals suffering from cluster headaches. Our procedure is less invasive and costs less.

 

Our expertise and in-depth therapeutic knowledge are driven by critical science and are free of industry manipulations.

 

We are a highly qualified specialist and medical provider passionate about providing long-term answers for all primary headaches and migraines. We cure but do not treat or abort migraine headaches. With all due respect to our scientific and pharmaceutical community, we announce the cure for migraine headaches in one treatment session will change the lives of our patients. 

 

We understand that pain, particularly migraine headaches, is part of the cosmic consciousness on Earth. Happiness and pain are twins. Happiness is absent whenever our body is in pain, and vice versa. Pain is a characteristic alignment of perishable creatures programmed by DNA on the blue planet, the Earth; in contrast, physical elements of the physical world and surrounding universe survive a long existence beyond our life. On the other hand, we understand that vegetative life is always under the direct influence of the physical world. Pain is part of life but not part of death.

 

An upregulated hypersensitivity of the parasympathetic reflex to repetitive physical or chemical stressors disrupts secure equilibrium, the integrity of the brain, and its reflective sensory organs. This immunologic reaction translates by a sophisticated signaling system in the Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), followed by eruption of neurotoxins such as TNF- . We speculate that migraine headaches are based on an immunologic process in response to physical elements of the planet Earth, the surrounding cosmic invisible rays, and the extra forces of physical nature. Primary migraine seems to be frequently reactivated by repeated confrontation with the physical forces surrounding us called triggers.  It initiates and provokes a series of cascades of complex immunologic neuroexcitation involving neurotoxins, ganglions, and specific brain centers. In molecular physiologic terms, we face a neurogenic hypersensitivity chain reaction called “Neuro allergy” to the forces of physics!

 

We understand that migraine headaches’ mechanism and process is a neurovascular dynamic. Vaso-constriction but not vaso-dilation in the property of peripheral sensory nerves initiates the signaling of neurotoxin synthesis. The regulation of this process is translated by incredible DNA encoding in the autonomous nerve system. A reactive response to potentially destructive vasoconstriction and hypoxia is vasodilation through upregulating break signals and spillover of the Calcium Gene Receptor Peptides in the properties of the CNS, peripheral ganglia, and peripheral nerves. It is known that the brain per se does not carry pain receptors; however, it contains the most robust immunomodulatory cells. We understand that repetitive signaling for chronic migraine headaches is related to dysbalance in the sympathetic and parasympathetic nerve systems, interrupting their equilibrium. The dysbalance kinetic upregulated toward hypersensitivity of the parasympathetic response by neurotoxin cascades implemented in the process. Our treatment suggested regulating the stability of the properties of the sympathetic and parasympathetic signaling systems, desensitizing the primarily hypersensitized sensory organ. We understand that repeated exposure to the same physical energy would trigger the process of migraine headaches even after years of being in silence. Auras of any type are concomitant signaling varieties of sensory organs, particularly the eyes, to the oncoming stimulus.

 

The upregulation of the proinflammatory toxins could be interrupted by certain anti-inflammatory drugs (NSAIDs), the Triptan family of drugs of selective serotonin receptor agonists. Even herbal supplements, darkness, and electrostimulation of the sensory nerves in the periphery essentially showed temporary interruption of the autonomous nerves, providing short-term relief. But not a cure or long-term relief.

 

What do we think about the current migraine and cluster headaches therapy by industry?

 

A review of the current treatment drugs and modalities demonstrated that the established hypothesis of the CGRP panel in the therapy of migraine headaches is short on their translational efficacy.

 

The notion of attacking the natural path of the immune reaction of the brain architectonics hierarchy by blocking the CGRP proteins was a misunderstanding. CGRP peptide synthesis does not produce neuroinflammatory toxins, nor  activation of B cell(NF-κB),  which cause pain and messengers in the central nervous system. Its synthesis is a reactive action to vasoconstriction and hypoxia in the property of peripheral nerves. An abrupt CGRP- -peptide synthesis by the immuno-glial cells of the brain in milliseconds is an immunological protective reaction, not a cause of migraine headaches or vasodilation. The histologic pattern of the Glia cells demonstrates intimate network connections to the brain vessels. 

The impact felt by market analysis is the continuous suffering of migraine headaches. It demonstrates erosion throughout the industry as patients and investors tried to understand the long-term effect of biosimilar entry, particularly on the innocent pediatric population. A critical literature review revealed that in the past 20 years, scientists and pharmaceutical manufacturers have tried to convince the world of the new biosimilar, CGRP- monoclonal antibodies and receptor blockers, with no significant therapeutic values for these biologics and biosimilars. In addition, this line of drugs made no difference to Triptans or non-steroidal anti-inflammatory drugs. Effective marketing of daily flourishing new biosimilars in scientific journals & conferences, television, and radio is far from the reality of effectively preventing and aborting migraine symptoms. Not even closer to cure. Patients and physicians are astonished by the frequent modification of treatment of migraine headaches by the defender of the CGRP hypothesis and their blooming monoclonal antibody products in the migraine treatment market. 

 

In the past decade, we recognized the discouraging failure of the CGRP and vasodilation hypothesis of migraine headaches and subsequent drugs of monoclonal Antibodies. 

 

The headaches community’s response to the frequent changing of new products biosimilars with the same pretended action with skeptics and disbelief. They look beyond the megalomania of introducing new routes of application and the decrease in the results of the biosimilars. This behavior is emphasized in the results of a decrease in the prescription of monoclonal antibodies by neurologists and primary care providers. The market has not been uniform across America and European countries. 

One primary reason each country’s economy has been deprived of billions of dollars in the standard health budget each year over the past decades is the sophisticated advertisement of speculative drugs or new biosimilars for migraine headaches. We live in real-time, and it is thoroughly challenging for consumers’ economies and productivity. Yet, we believe in humanity more than industry. So, ultimately, we decided to introduce our knowledge and discovery of FURROW formula by teaching and to open our explorative expertise to all headaches communities to resolve migraine and cluster headaches without extravagant financial gain. Let’s stop experimenting with the lives of innocent people. Did we hurt anyone? Our apologies!

 

CURE MIGRAINE WORLDWIDE & RESEARCH, LLC.